Cat. No. 4205
Chemical Name: N'-[(3Z)-1-Hexyl-2-oxo-1,2-dihydro-3
Biological ActivityCB2 receptor agonist. Displays 4-fold higher affinity for the human CB2 receptor than the human CB1 receptor (Ki values are 43.3 and 162.4 nM respectively); shows 70-fold affinity for the rat CB2 receptor over the rat CB1 receptor (Ki values are 16.3 and 1130 nM respectively). Attenuates tactile allodynia in a rat model; does not affect rat locomotor activity.
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
Certificate of Analysis / Product Datasheet / Safety Datasheet
References are publications that support the products' biological activity.
Xu et al (2010) Pharmacological characterization of a novel cannabinoid ligand, MDA19, for treatment of neuropathic pain. Anesth.Analg. 111 99. PMID: 20522703.
Diaz et al (2008) Design and synthesis of a novel series of N-alkyl isatin acylhydrazone derivatives that act as selective cannabinoid receptor 2 agonists for the treatment of neuropathic pain. J.Med.Chem. 51 4932. PMID: 18666769.
If you know of a relevant reference for MDA 19 please let us know.
Citations are publications that use Tocris products.
Do you know of a great paper that uses MDA 19 from Tocris? If so please let us know.
View Related Products by Product Action
Keywords: MDA 19, supplier, MDA19, cb2, cannabinoid, agonists, Tocris Bioscience, CB2 Receptor Agonist products
Find multiple products by catalog number
New Products in this Area
Potent and selective CB2 partial agonist; orally biovailable
Follow Tocris on LinkedIn
Visit our LinkedIn page for the latest Tocris news, events and updates.